Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Vermylen

Showing results (1-10 of 373) with videos related to

Pageof 38
Sort By:
Journal of Thrombosis and Haemostasis : JTH|June 28, 2005
More on: uncertain times for research on hemophilia and allied disordersJ Vermylen
Journal of Thrombosis and Haemostasis : JTH|November 23, 2006
More on: 'new light on an old story: von Willebrand factor binding to collagen'J Vermylen
Thrombosis and Haemostasis|July 1, 1995
Clinical trials of primary and secondary prevention of thrombosis and restenosisJ Vermylen
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 1999
How do some haemophiliacs develop inhibitors?J Vermylen
Acta Clinica Belgica|January 1, 1975
Clinical pharmacology of anti-aggregating substancesJ Vermylen
Pathologie-Biologie|December 1, 1975
Physical and chemical properties of normal and haemophilic factor VIIIJ Vermylen
Verhandelingen - Koninklijke Vlaamse Academie Voor Geneeskunde Van Belgie|January 1, 1972
Fibrinogen derivatives. A laboratory and clinical studyJ Vermylen
Revue Medicale De Bruxelles|February 4, 2006
[New therapeutic perspectives in hemophilia]J Vermylen
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 1, 1995
Approaching the ideal: therapeutic requirements for factor VIII concentratesJ Vermylen
Acta Chirurgica Belgica|January 1, 1970
[Blood coagulation problems in the surgical patient]J Vermylen
Pageof 38

Showing results (1-10 of 373) with videos related to

Sort By:
Pageof 38
Journal of Thrombosis and Haemostasis : JTH|June 28, 2005
More on: uncertain times for research on hemophilia and allied disordersJ Vermylen
Journal of Thrombosis and Haemostasis : JTH|November 23, 2006
More on: 'new light on an old story: von Willebrand factor binding to collagen'J Vermylen
Thrombosis and Haemostasis|July 1, 1995
Clinical trials of primary and secondary prevention of thrombosis and restenosisJ Vermylen
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 1999
How do some haemophiliacs develop inhibitors?J Vermylen
Acta Clinica Belgica|January 1, 1975
Clinical pharmacology of anti-aggregating substancesJ Vermylen
Pathologie-Biologie|December 1, 1975
Physical and chemical properties of normal and haemophilic factor VIIIJ Vermylen
Verhandelingen - Koninklijke Vlaamse Academie Voor Geneeskunde Van Belgie|January 1, 1972
Fibrinogen derivatives. A laboratory and clinical studyJ Vermylen
Revue Medicale De Bruxelles|February 4, 2006
[New therapeutic perspectives in hemophilia]J Vermylen
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 1, 1995
Approaching the ideal: therapeutic requirements for factor VIII concentratesJ Vermylen
Acta Chirurgica Belgica|January 1, 1970
[Blood coagulation problems in the surgical patient]J Vermylen
Pageof 38